Close
4

Find Tenatoprazole manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 113712-98-4, Tu-199, Ulsacare, Protop, Tu 199, Tenatoprazole [inn]
Molecular Formula
C16H18N4O3S
Molecular Weight
346.4  g/mol
InChI Key
ZBFDAUIVDSSISP-UHFFFAOYSA-N
FDA UNII
RE0689TX2K

Tenatoprazole
1 2D Structure

Tenatoprazole

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-imidazo[4,5-b]pyridine
2.1.2 InChI
InChI=1S/C16H18N4O3S/c1-9-7-17-12(10(2)14(9)23-4)8-24(21)16-18-11-5-6-13(22-3)19-15(11)20-16/h5-7H,8H2,1-4H3,(H,18,19,20)
2.1.3 InChI Key
ZBFDAUIVDSSISP-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=CC(=N3)OC
2.2 Other Identifiers
2.2.1 UNII
RE0689TX2K
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 5-methoxy-2-(((4-methoxy-3,5-dimethylpyrid-2-yl)methyl)sulfinyl)-1h-imidazo(4,5-b)pyridine

2. 5-methyl-2((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl-imidazo(4,5-b)pyridine

3. Tu 199

4. Tu-199

5. Tu199

2.3.2 Depositor-Supplied Synonyms

1. 113712-98-4

2. Tu-199

3. Ulsacare

4. Protop

5. Tu 199

6. Tenatoprazole [inn]

7. Tu199

8. Re0689tx2k

9. (r)-tenatoprazole

10. 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1h-imidazo[4,5-b]pyridine

11. Ncgc00167521-01

12. Dsstox_cid_26687

13. Dsstox_rid_81821

14. Dsstox_gsid_46687

15. 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1h-imidazo[4,5-b]pyridine

16. 3h-imidazo[4,5-b]pyridine, 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-

17. Cas-113712-98-4

18. Unii-re0689tx2k

19. Benatoprazole

20. 3h-imidazo(4,5-b)pyridine, 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-

21. 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)-1h-imidazo(4,5-b)pyridine

22. 5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl)-1h-imidazo[4,5-b]pyridine

23. 705969-00-2

24. Tenatoprazole (jan/inn)

25. Tenatoprazole [jan]

26. Schembl323288

27. Tenatoprazole [mart.]

28. (+/-)-tenatoprazole

29. Stu-199

30. Tenatoprazole [who-dd]

31. Chembl1475252

32. Dtxsid1046687

33. Chebi:94379

34. Tenatoprazole, >=98% (hplc)

35. Hms2090b06

36. Hms3713d12

37. (-)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]imidazo[4,5-b]pyridine

38. Amy22647

39. Bcp09130

40. Tox21_112518

41. Bdbm50402289

42. S4212

43. Akos015895166

44. Akos015969750

45. Tox21_112518_1

46. Ccg-213826

47. Sb16956

48. 5-methoxy-2-(((4-methoxy-3,5-dimethylpyrid-2-yl)methyl)sulfinyl)-1h-imidazo(4,5-b)pyridine

49. 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1h-imidazo[4,5-b]pyridine

50. 5-methyl-2((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl-imidazo(4,5-b)pyridine

51. Ncgc00167521-02

52. Ncgc00167521-06

53. Ncgc00386399-04

54. 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1h-imidazo(4,5-b)pyridine

55. Ac-12822

56. Ac-35641

57. As-76013

58. Hy-17421

59. Cs-0007867

60. Ft-0631071

61. D01920

62. Ab01275522-01

63. Ab01275522_02

64. 712t984

65. A803083

66. Sr-01000872709

67. J-003010

68. Q4822824

69. Sr-01000872709-1

70. Brd-a42270467-001-01-0

71. Brd-a42270467-001-02-8

72. (+-)-5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)-1h-imidazo(4,5-b)pyridine

73. (+/-)-5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)-1h-imidazo(4,5-b)pyridine

74. (-)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]imidazo[4,5-b]pyridine

75. 1h-imidazo(4,5-b)pyridine, 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-

76. 1h-imidazo(4,5-b)pyridine, 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-(9ci

77. 2-(2-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-5-methoxyimidazo(4,5-b)pyridine

78. 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-3h-imidazo(4,5-b)pyridine

79. 5-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1h-imidazo[4,5-b]pyridine

80. 5-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-3h-imidazo[4,5-b]pyridine

81. 5-methoxy-2-{[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulphinyl}-1h-imidazo[4,5-b]pyridine

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 346.4 g/mol
Molecular Formula C16H18N4O3S
XLogP31.8
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count7
Rotatable Bond Count5
Exact Mass346.10996162 g/mol
Monoisotopic Mass346.10996162 g/mol
Topological Polar Surface Area109 Ų
Heavy Atom Count24
Formal Charge0
Complexity455
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty